SCHEMBL7985772

SCHEMBL7985772

CCc1nc(O)c2c(ncn2CCOc2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
CNOT7 Q9UIV1 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
LTA4H P09960 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.38
PTPN7 P35236 1/20 0.38
DUSP3 P51452 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TBXAS1 P24557 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985536 0.94 SMN1; SMN2 (0.42) L3MBTL1CNOT7NPC1RAB9ALTA4H
SCHEMBL7975252 0.80 HPGD (0.45) CNOT7SMN1; SMN2TSHRGAAALDH1A1
SCHEMBL7984482 0.77 GBA1 (0.42) L3MBTL1CNOT7NPC1RAB9ALTA4H
SCHEMBL7973934 0.76 CYP11B1 (0.45) SMN1; SMN2GAAALDH1A1
SCHEMBL7985082 0.75 HTT (0.46) CNOT7HTTLMNATSHRALDH1A1
SCHEMBL7985651 0.75 CYP1A2 (0.41) SMN1; SMN2GAAALDH1A1
SCHEMBL7984512 0.74 GAA (0.50) LMNAGAA
SCHEMBL7988883 0.74 CYP11B1 (0.46) L3MBTL1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL7985770 0.74 CNOT7 (0.50) L3MBTL1CNOT7NPC1RAB9ALTA4H
SCHEMBL7987235 0.73 TSHR (0.46) CNOT7TLR7HTTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed